Downsides of Innovation Mania
(Revised and expanded July 4th, 2018. Happy Independence from Consumerism Day!)
You probably sense as I do that normality isn’t what it used to be, even a few years ago. I’m talking not about Trump or politics but of the magnificent panoply of digital technologies we are immersed if not drowning in. The speed at which technologists are shoving stuff at us has bugged me for quite some time. Understanding innovation mania has caused me to spend years puzzling out what’s driving the complexification of nearly everything and how the new ways we are obliged to adopt might transform concepts of what human nature is.
Why, I wonder, is everything possible being digitized as quickly as possible? I hate to use the phrase, but might there be some “intelligent design” that drives humans to churn out technology, faster and faster? More importantly, whom or what are we serving with our clever innovations, especially those that render what once was tangible into bits? Continue reading “When Momma Ain’t Happy”
It is considered bad form for journalists to refer to the US government as a “regime.” Apparently, that moniker is reserved for our country’s enemies, of late Russia, North Korea, Iran, and Syria. Maybe Myanmar too; that’s still being sorted out. But what is a regime, really, and is it really true that we don’t have one here? Continue reading “One Regime to Rule them All”
Perhaps you haven’t noticed the investor class getting all gung-ho these days over Artificial Intelligence (AI). Only a couple of decades ago, these same people dismissed AI because it wasn’t very useful yet. But that’s all changed due to advances in machine vision and learning, and now VCs, hedge funds, and most of the rest of the usual big-money suspects are salivating over prospects of automating most of the rest of the economy, even including agriculture.
Thanks to its clot of institutions of higher learning, Boston—my fair city—is littered with tech startups and factories that churn them out. They and the Hub’s cloud of serial investors have created a knot of compressed energy, the nexus of which one can find at a suite in Kendall Square—epicenter of Boston’s tech scene, featuring outposts of Google, Oracle, Facebook and Amazon, pharma firms like Merck and Novartis and a host of biotechy startups fed by MIT’s biomedical research complex, augmented by its AI and Media Labs—where every Thursday evening prime movers get together for suds and savvy strategizing at private oasis called Venture Café. Continue reading “A.I. Enablers Gear Up to Assault Intellect”